trial-designer

To compare clinical trial designs, you analyze design elements like endpoints, patient populations, duration, comparators, and sample size. This Skill systematically compares these elements between competing trials and applies FDA and EMA regulatory guidelines to provide strategic insights.

The best way to analyze clinical trial endpoints against regulatory guidelines is to evaluate design choices for FDA and EMA compliance. This Skill uses CT.gov v2 API and openFDA data to assess how your trial endpoints and study duration align with current regulatory standards.

Yes, you can use ClinicalTrials.gov data to understand strategic intentions behind trial design choices. By extracting patient population and comparator data via the CT.gov v2 API, this Skill analyzes the strategic rationale and competitive positioning of competing clinical trials.

Yes, clinical trial protocol comparison requires access to the CT.gov v2 API and openFDA. These dependencies provide the necessary trial registration data and regulatory context to perform systematic design analysis and protocol comparison.

To evaluate sample size and patient population differences, you compare the specific design elements extracted from clinical trial records. This Skill processes competing trial data to highlight variations in sample size and population criteria, revealing strategic trial design intentions.